Based on their kinetics and toxicity profiles, polymyxin B may be the preferred agent for treatment of systemic infections, while colistin is preferred for infections limited to the urinary tract.
PHARMACOLOGY UPDATE
Colistin vs. Polymyxin B
July 1, 2016